Memantine - Wikipedia, the free encyclopedia
Memantine is also being tested for opioid dependence, systemic lupus ... reversible neurological impairment in multiple sclerosis, that led to stop ...
Memantine Therapy for Multiple Sclerosis - Full Text View ...
Pilot Clinical Trial With Memantine for Cognitive Deficits in Patients With Multiple Sclerosis ... Multiple Sclerosis. Demyelinating Diseases. Memantine ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... Gender: Following multiple dose administration of Namenda 20 mg b.i.d., females ...
PatientsLikeMe : Memantine Treatment Report
Memantine: Find the most comprehensive real-world treatment information on ... Why Patients Stopped Taking Memantine (multiple reasons could be selected) Reason ...
memantine.com - Preclinical Data of Memantine
Memantine is an NMDA receptor antagonist that has been recently approved in EU ... because the pathomechanism of Alzheimer's disease involves multiple contributing ...
Pharmacokinetics of single-dose and multiple-dose memantine in healthy ...
... plasma concentration of memantine after multiple-dose administration was greater ... suggesting memantine accumulation with multiple-dose administration of ...
Memantine for Spasticity in MS Patients - Full Text View ...
Multiple Sclerosis. Drug: placebo. Drug: memantine. Phase IV ... Multiple Sclerosis. Demyelinating Diseases. Memantine. Demyelinating Autoimmune Diseases, CNS ...
Memantine: Information from Answers.com
Memantine Memantine is a new drug for treating Alzheimer's disease, mental ... reversible neurological impairment in multiple sclerosis, that led to stop ...
memantine.com - Co-administration of Memantine with ...
Multiple studies in the last two decades revealed degeneration of cholinergic ... These preclinical results were further confirmed in multiple clinical trials. ...
MEMANTINE at www.arlingtonmedia.org!
Best MEMANTINE links & users bookmarks collection on www.arlingtonmedia.org domain! ... evaluate the effect of multiple doses of memantine on the pharmacokinetics of ...
|
The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study -- Shery et al. 90 (7): 839 -- British Journal of Ophthalmology
Published Online First: 23 March 2006. doi:10.1136/bjo.2005.086322 LogMAR visual acuity measured on Snellen charts and the peak to peak amplitude of nystagmus measured in the worse eye (eye with the maximum amplitude of nystagmus) before and after treatment with gabapentin, in patients with multiple sclerosis (A and B); idiopathic infantile nystagmus and nystagmus associated with ocular pathology (C and D); and patients with MS treated with memantine (E and F).